SCHEMBL21937310

SCHEMBL21937310

C=Cc1cc(N=N)c(NC)c(F)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19431556 0.69 — —
SCHEMBL21936231 0.66 — —
SCHEMBL23252478 0.63 RAPGEF4 (0.37) —
SCHEMBL31448050 0.63 ESR1 (0.31) —
SCHEMBL970210 0.63 ESR1 (0.31) —
SCHEMBL23519805 0.62 — —
SCHEMBL18879669 0.62 — —
SCHEMBL19431559 0.62 — —
SCHEMBL4537972 0.61 — —
SCHEMBL28680712 0.60 RAPGEF4 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3633380-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 — — EP disclosed
Send feedback